Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 21, 2014

Primary Completion Date

April 9, 2014

Study Completion Date

April 15, 2014

Conditions

Healthy

Interventions

DRUG

Placebo to BI 1026706

Placebo tablet

DRUG

Pregabalin

Pregabalin hard capsule

DRUG

BI 1026706

BI 1026706 oral solution

DRUG

Celecoxib

Celecoxib hard capsule

Trial Locations (1)

1320.3.1 Boehringer Ingelheim Investigational Site, Dörnach